These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29159771)

  • 21. Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.
    Salaroglio IC; Gazzano E; Abdullrahman A; Mungo E; Castella B; Abd-Elrahman GEFA; Massaia M; Donadelli M; Rubinstein M; Riganti C; Kopecka J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):286. PubMed ID: 30482226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CLDN6 inhibits breast cancer cell malignant behavior by suppressing ERK signaling.
    Lu Y; Shao Y; Xie Y; Qu H; Qi D; Dong Y; Jin Q; Wang L; Wei J; Quan C
    Cell Signal; 2022 Sep; 97():110393. PubMed ID: 35752352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel chalcone-based molecule, BDP inhibits MDA‑MB‑231 triple-negative breast cancer cell growth by suppressing Hsp90 function.
    Oh YJ; Seo YH
    Oncol Rep; 2017 Oct; 38(4):2343-2350. PubMed ID: 28849241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
    Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
    J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
    Wu J; Sun Z; Sun H; Li Y
    Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple-negative breast cancer cells.
    Wu J; Li J; Xu H; Qiu N; Huang X; Li H
    Lipids Health Dis; 2023 Sep; 22(1):153. PubMed ID: 37716956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
    Rahimian A; Barati G; Mehrandish R; Mellati AA
    Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers.
    Cheriyan VT; Muthu M; Patel K; Sekhar S; Rajeswaran W; Larsen SD; Polin L; Levi E; Singh M; Rishi AK
    Oncotarget; 2016 Nov; 7(45):73370-73388. PubMed ID: 27687593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNFR2 promotes Adriamycin resistance in breast cancer cells by repairing DNA damage.
    Yang F; Zhao N; Wu N
    Mol Med Rep; 2017 Sep; 16(3):2962-2968. PubMed ID: 28677724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.
    González-Ortiz A; Pulido-Capiz A; Castañeda-Sánchez CY; Ibarra-López E; Galindo-Hernández O; Calderón-Fernández MA; López-Cossio LY; Díaz-Molina R; Chimal-Vega B; Serafín-Higuera N; Córdova-Guerrero I; García-González V
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the Tight Junction Protein CLDN6 on Cell Migration and Invasion in High-Grade Meningioma.
    Yang A; Yang X; Wang J; Wang X; Wu H; Fan L; Li H; Li J
    World Neurosurg; 2021 Jul; 151():e208-e216. PubMed ID: 33862296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.
    You KS; Yi YW; Kwak SJ; Seong YS
    Int J Oncol; 2018 Mar; 52(3):828-840. PubMed ID: 29344641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
    Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN
    Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer.
    Sun TT; Wang Y; Cheng H; Xiao HZ; Xiang JJ; Zhang JT; Yu SB; Martin TA; Ye L; Tsang LL; Jiang WG; Xiaohua J; Chan HC
    Biochim Biophys Acta; 2014 Mar; 1843(3):618-28. PubMed ID: 24373847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Tumour Biol; 2016 Apr; 37(4):4991-9. PubMed ID: 26537583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CircRNA_0044556 diminishes the sensitivity of triple‑negative breast cancer cells to adriamycin by sponging miR‑145 and regulating NRAS.
    Chen J; Shi P; Zhang J; Li Y; Ma J; Zhang Y; Liu H
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ST8SIA1 inhibition sensitizes triple negative breast cancer to chemotherapy via suppressing Wnt/β-catenin and FAK/Akt/mTOR.
    Wan H; Li Z; Wang H; Cai F; Wang L
    Clin Transl Oncol; 2021 Apr; 23(4):902-910. PubMed ID: 32939659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.